Featured Research

from universities, journals, and other organizations

Mayo Clinic Researchers Explore New Methods To Detect Parkinson's Disease In At-Risk Individuals

Date:
July 6, 1999
Source:
Mayo Clinic
Summary:
Mayo Clinic neurologists are using existing technology and an investigational drug to detect pre-symptomatic Parkinson's disease in at-risk people who have family members with Parkinson's disease. A study detailing the results of this new approach appears in the July issue of Mayo Clinic Proceedings.

ROCHESTER, MINN.-- Mayo Clinic neurologists are using existing technology and an investigational drug to detect pre-symptomatic Parkinson's disease in at-risk people who have family members with Parkinson's disease. A study detailing the results of this new approach appears in the July issue of Mayo Clinic Proceedings.

The study makes use of a widely available brain imaging technique, single-photon emission computed tomography (SPECT), in combination with the investigational radiopharmaceutical beta CIT. The beta CIT drug binds to the specific nerve cells in the brain that decrease in number when a patient has Parkinson's disease. The SPECT camera is able to measure how much of the drug binds to the remaining nerve cells in the brain. Through these methods, Mayo Clinic researchers were able to differentiate between 10 Parkinson's disease patients and 10 control individuals. As expected, the amount of the drug that was detected for the Parkinsons disease patients was reduced.

The Mayo Clinic researchers also studied 10 relatives of Parkinson disease patients and found that the amount of the drug that bound to the nerve cells in their brain fell in a range between that of the Parkinson's disease patients and the controls.

"Our goal is to determine who is really at risk before people actually develop the symptoms of Parkinson's disease," says Demetrius M. Maraganore, M.D., a Mayo Clinic neurologist and the lead author of the study. "We know from a recent Mayo Clinic study that overall there is a three percent lifetime risk of developing Parkinson's disease. We also know that for persons having two or more relatives with Parkinson's disease, their lifetime risk is increased to nearly 30 percent. For the current U.S. population, an estimated 200,000 people have this risk factor. This high-risk group is likely larger when one considers other independent risk factors.

"The key for future research of Parkinson's disease is to find ways to discover who is most at risk and to develop therapies that can delay or prevent the onset of this disease," says Dr. Maraganore. "The results of our study are very encouraging, but clearly there needs to be continuing research and development in this area."


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "Mayo Clinic Researchers Explore New Methods To Detect Parkinson's Disease In At-Risk Individuals." ScienceDaily. ScienceDaily, 6 July 1999. <www.sciencedaily.com/releases/1999/07/990706070551.htm>.
Mayo Clinic. (1999, July 6). Mayo Clinic Researchers Explore New Methods To Detect Parkinson's Disease In At-Risk Individuals. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/1999/07/990706070551.htm
Mayo Clinic. "Mayo Clinic Researchers Explore New Methods To Detect Parkinson's Disease In At-Risk Individuals." ScienceDaily. www.sciencedaily.com/releases/1999/07/990706070551.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com
Ebola Vaccine Trial Gets Underway at Oxford University

Ebola Vaccine Trial Gets Underway at Oxford University

AFP (Sep. 17, 2014) A healthy British volunteer is to become the first person to receive a new vaccine for the Ebola virus after US President Barack Obama called for action against the epidemic and warned it was "spiralling out of control." Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Obesity Rates Steady Even As Americans' Waistlines Expand

Obesity Rates Steady Even As Americans' Waistlines Expand

Newsy (Sep. 17, 2014) Researchers are puzzled as to why obesity rates remain relatively stable as average waistlines continue to expand. Video provided by Newsy
Powered by NewsLook.com
President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins